Hepatic gene expression profiling in Nrf2 knockout mice after long-term high-fat diet-induced obesity

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Chartoumpekis, Dionysios V ^a,b   Ziros, Panos G ^a   Zaravinos, Apostolos ^c,d   Iskrenova, Ralitsa P ^a   Psyrogiannis, Agathoklis I ^a   Kyriazopoulou, Venetsana E ^a   Sykiotis, Gerasimos P ^a   Habeos, Ioannis G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CRETE   (Greece)

^d UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

DETOXIFICATION GENE; DIET-INDUCED OBESITY; GENE EXPRESSION PROFILES; HEPATIC GENE EXPRESSIONS; METABOLIC REGULATIONS; MICROARRAY ANALYSIS; QUANTITATIVE REAL-TIME RT-PCR; TRANSCRIPTOME PROFILING;

DETOXIFICATION; GENES; METABOLISM; NUTRITION; PLANTS (BOTANY); POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION FACTORS;

MAMMALS;

AQUAPORIN 8; CARBONYL REDUCTASE; CHOLESTEROL 7ALPHA MONOOXYGENASE; CONSTITUTIVE ANDROSTANE RECEPTOR; LIPOCALIN; RNA; TRANSCRIPTION FACTOR NRF2; MESSENGER RNA; NFE2L2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; LIPID DIET; MALE; METABOLIC REGULATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY; REPRODUCIBILITY; SIGNAL TRANSDUCTION; TIME;

ANIMALS; DIET, HIGH-FAT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE REGULATORY NETWORKS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84877276025     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/340731     Document Type: Article

References (61)

1. Haffner S., Taegtmeyer H., Epidemic obesity and the metabolic syndrome. Circulation 2003 108 13 1541 1545 2-s2.0-0141506880 10.1161/01.CIR.0000088845. 17586.EC (Pubitemid 37187777)
2. James P. T., Leach R., Kalamara E., Shayeghi M., The worldwide obesity epidemic. Obesity Research 2001 9 supplement 4 228S 233S
3. Calle E. E., Kaaks R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer 2004 4 8 579 591 2-s2.0-3543072186 (Pubitemid 39025053)
4. Bergman R. N., Kim S. P., Hsu I. R., Catalano K. J., Chiu J. D., Kabir M., Richey J. M., Ader M., Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. American Journal of Medicine 2007 120 2, supplement 1 3 8
5. Sykiotis G. P., Habeos I. G., Samuelson A. V., Bohmann D., The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Current Opinion in Clinical Nutrition and Metabolic Care 2011 14 1 41 48 2-s2.0-79851508187 10.1097/MCO.0b013e32834136f2
6. Calkins M. J., Johnson D. A., Townsend J. A., Vargas M. R., Dowell J. A., Williamson T. P., Kraft A. D., Lee J. M., Li J., Johnson J. A., The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxidants and Redox Signaling 2009 11 3 497 508 2-s2.0-58849110632 10.1089/ars.2008.2242
7. Kobayashi M., Yamamoto M., Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Advances in Enzyme Regulation 2006 46 1 113 140 2-s2.0-33748052967 10.1016/j.advenzreg.2006.01.007 (Pubitemid 44301353)
8. Sykiotis G. P., Bohmann D., Stress-activated cap'n'collar transcription factors in aging and human disease. Science Signaling 2010 3 112 re3 2-s2.0-77953012548 10.1126/scisignal.3112re3
9. Kensler T. W., Wakabayashi N., Biswal S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology 2007 47 89 116 2-s2.0-33847050801 10.1146/annurev.pharmtox.46.120604.141046
10. Osburn W. O., Kensler T. W., Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutation Research 2008 659 1-2 31 39 2-s2.0-47849083585 10.1016/j.mrrev.2007.11.006
11. Lee J. M., Li J., Johnson D. A., Stein T. D., Kraft A. D., Calkins M. J., Jakel R. J., Johnson J. A., Nrf2, a multi-organ protector? FASEB Journal 2005 19 9 1061 1066 2-s2.0-21744445077 10.1096/fj.04-2591hyp (Pubitemid 40946431)
12. Motohashi H., Yamamoto M., Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends in Molecular Medicine 2004 10 11 549 557 2-s2.0-7244253081 10.1016/j.molmed.2004.09.003 (Pubitemid 39433824)
13. Chartoumpekis D. V., Ziros P. G., Psyrogiannis A. I., Papavassiliou A. G., Kyriazopoulou V. E., Sykiotis G. P., Habeos I. G., Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes 2011 60 10 2465 2473
14. Pi J., Leung L., Xue P., Wang W., Hou Y., Liu D., Yehuda-Shnaidman E., Lee C., Lau J., Kurtz T. W., Chan J. Y., Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. Journal of Biological Chemistry 2010 285 12 9292 9300 2-s2.0-77950553993 10.1074/jbc.M109.093955
15. Zhang Y. K., Wu K. C., Liu J., Klaassen C. D., Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. Toxicology and Applied Pharmacology 2012 264 3 305 314 10.1016/j.taap.2012.09.014
16. Meher A. K., Sharma P. R., Lira V. A., Yamamoto M., Kensler T. W., Yan Z., Leitinger N., Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance. Free Radical Biology & Medicine 2012 52 9 1708 1715 10.1016/j.freeradbiomed.2012.02.022
17. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. I., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications 1997 236 2 313 322 2-s2.0-0031577292 10.1006/bbrc.1997.6943 (Pubitemid 27373291)
18. Saeed A. I., Bhagabati N. K., Braisted J. C., Liang W., Sharov V., Howe E. A., Li J., Thiagarajan M., White J. A., Quackenbush J., TM4 microarray software suite. Methods in Enzymology 2006 411 134 193 2-s2.0-33747894577 10.1016/S0076-6879(06)11009-5 (Pubitemid 44291425)
19. Saeed A. I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., Quackenbush J., TM4: a free, open-source system for microarray data management and analysis. BioTechniques 2003 34 2 374 378 2-s2.0-0037311919 (Pubitemid 36184095)
20. Zhang B., Kirov S., Snoddy J., WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Research 2005 33 2 W741 W748 2-s2.0-23144464901 10.1093/nar/gki475 (Pubitemid 44530021)
21. Zaravinos A., Lambrou G. I., Boulalas I., Delakas D., Spandidos D. A., Identification of common differentially expressed genes in urinary bladder cancer. PLoS ONE 2011 6 4 2-s2.0-79953682249 10.1371/journal.pone.0018135 e18135
22. Pfaffl M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001 29 9, article e45 2-s2.0-17344392308
23. Spandidos A., Wang X., Wang H., Dragnev S., Thurber T., Seed B., A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance. BMC Genomics 2008 9 article 633 2-s2.0-58949097577 10.1186/1471-2164-9-633
24. Spandidos A., Wang X., Wang H., Seed B., PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Research 2010 38 1 D792 D799 2-s2.0-75549089019 10.1093/nar/gkp1005
25. Wang X., Seed B., A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Research 2003 31 24, article e154 10.1093/nar/gng154
26. Zhang Y., Cheng X., Aleksunes L., Klaassen C. D., Transcription factor-mediated regulation of carboxylesterase enzymes in livers of mice. Drug Metabolism and Disposition 2012 40 6 1191 1197
27. Hayes J. D., Chanas S. A., Henderson C. J., McMahon M., Sun C., Moffat G. J., Wolf C. R., Yamamoto M., The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochemical Society Transactions 2000 28 2 33 41 2-s2.0-0033956744 (Pubitemid 30103209)
28. Yates M. S., Kwak M. K., Egner P. A., Groopman J. D., Bodreddigari S., Sutter T. R., Baumgartner K. J., Roebuck B. D., Liby K. T., Yore M. M., Honda T., Gribble G. W., Sporn M. B., Kensler T. W., Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1, 9(11)-dien-28-oyl]imidazole. Cancer Research 2006 66 4 2488 2494 2-s2.0-33644537902 10.1158/0008-5472.CAN-05- 3823
29. Nioi P., McMahon M., Itoh K., Yamamoto M., Hayes J. D., Identification of a novel NRF2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochemical Journal 2003 374 2 337 348 2-s2.0-0042330074 10.1042/BJ20030754 (Pubitemid 37094093)
30. Thimmulappa R. K., Lee H., Rangasamy T., Reddy S. P., Yamamoto M., Kensler T. W., Biswal S., Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. Journal of Clinical Investigation 2006 116 4 984 995 2-s2.0-33645530745 10.1172/JCI25790
31. Itoh K., Mochizuki M., Ishii Y., Ishii T., Shibata T., Kawamoto Y., Kelly V., Sekizawa K., Uchida K., Yamamoto M., Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Δ12,14-prostaglandin j(2). Molecular and Cellular Biology 2004 24 1 36 45 2-s2.0-10744230015 10.1128/MCB.24.1.36-45.2004 (Pubitemid 38010033)
32. Innamorato N. G., Rojo A. I., García-Yagüe Á. J., Yamamoto M., De Ceballos M. L., Cuadrado A., The transcription factor nrf2 is a therapeutic target against brain inflammation. Journal of Immunology 2008 181 1 680 689 2-s2.0-47949083810
33. Li N., Nel A. E., Role of the Nrf2-mediated signaling pathway as a negative regulator of inflammation: implications for the impact of particulate pollutants on asthma. Antioxidants and Redox Signaling 2006 8 1-2 88 98 2-s2.0-33644652410 10.1089/ars.2006.8.88 (Pubitemid 43324534)
34. Chanas S. A., Jiang Q., McMahon M., McWalter G. K., McLellan L. I., Elcombe C. R., Henderson C. J., Wolf C. R., Moffat G. J., Itoh K., Yamamoto M., Hayes J. D., Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochemical Journal 2002 365 2 405 416 2-s2.0-0037101768 10.1042/BJ20020320 (Pubitemid 36135312)
35. Thimmulappa R. K., Mai K. H., Srisuma S., Kensler T. W., Yamamoto M., Biswal S., Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Research 2002 62 18 5196 5203 2-s2.0-0037106099 (Pubitemid 35033454)
36. Tanaka Y., Aleksunes L. M., Yeager R. L., Gyamfi M. A., Esterly N., Guo G. L., Klaassen C. D., NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. Journal of Pharmacology and Experimental Therapeutics 2008 325 2 655 664 2-s2.0-42449111723 10.1124/jpet.107.135822 (Pubitemid 351574806)
37. Zhang Y. K. J., Guo G. L., Klaassen C. D., Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters. PLoS ONE 2011 6 2 2-s2.0-79951571030 10.1371/journal.pone.0016683 e16683
38. Huang J., Tabbi-Anneni I., Gunda V., Wang L., Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. American Journal of Physiology 2010 299 6 G1211 G1221 2-s2.0-78649746191 10.1152/ajpgi.00322.2010
39. Yiu W. F., Kwan P. L., Wong C. Y., Kam T. S., Chiu S. M., Chan S. W., Chan R., Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase. Journal of Food Science 2011 76 3 H80 H89 2-s2.0-79954992709 10.1111/j.1750-3841.2011.02042.x
40. Slegenthaler G., Hotz R., Chatellard-Gruaz D., Jaconi S., Saurat J. H., Characterization and expression of a novel human fatty acid-binding protein: the epidermal type (E-FABP). Biochemical and Biophysical Research Communications 1993 190 2 482 487 2-s2.0-0027326909 10.1006/bbrc.1993.1073 (Pubitemid 23209636)
41. Hoekstra M., Stitzinger M., Van Wanrooij E. J. A., Michon I. N., Kruijt J. K., Kamphorst J., Van Eck M., Vreugdenhil E., Van Berkel T. J. C., Kuiper J., Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet. Journal of Lipid Research 2006 47 10 2198 2207 2-s2.0-33845590834 10.1194/jlr.M600095-JLR200 (Pubitemid 44936130)
42. Toye A. A., Dumas M. E., Blancher C., Rothwell A. R., Fearnside J. F., Wilder S. P., Bihoreau M. T., Cloarec O., Azzouzi I., Young S., Barton R. H., Holmes E., McCarthy M. I., Tatoud R., Nicholson J. K., Scott J., Gauguier D., Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia 2007 50 9 1867 1879 2-s2.0-34547674398 10.1007/s00125-007-0738-5 (Pubitemid 47222857)
43. Kitteringham N. R., Abdullah A., Walsh J., Randle L., Jenkins R. E., Sison R., Goldring C. E. P., Powell H., Sanderson C., Williams S., Higgins L., Yamamoto M., Hayes J., Park B. K., Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. Journal of Proteomics 2010 73 8 1612 1631 2-s2.0-77953290236 10.1016/j.jprot.2010.03.018
44. Wei P., Zhang J., Egan-Haftey M., Liang S., Moore D. D., The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000 407 6806 920 923 2-s2.0-0034687397 10.1038/35038112
45. Wada T., Gao J., Xie W., PXR and CAR in energy metabolism. Trends in Endocrinology and Metabolism 2009 20 6 273 279 2-s2.0-68149159139 10.1016/j.tem.2009.03.003
46. Gao J., He J., Zhai Y., Wada T., Xie W., The constitutive androstane receptor is an anti-obesity nuclear receptor that improves in sulin sensitivity. Journal of Biological Chemistry 2009 284 38 25984 25992 2-s2.0-70350031574 10.1074/jbc.M109.016808
47. Dong B., Saha P. K., Huang W., Chen W., Abu-Elheiga L. A., Wakil S. J., Stevens R. D., Ilkayeva O., Newgard C. B., Chan L., Moore D. D., Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proceedings of the National Academy of Sciences of the United States of America 2009 106 44 18831 18836
48. Honkakoski P., Zelko I., Sueyoshi T., Negishi M., The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital- responsive enhancer module of the CYP2B gene. Molecular and Cellular Biology 1998 18 10 5652 5658 2-s2.0-0031682988 (Pubitemid 28450516)
49. Anwar-Mohamed A., Degenhardt O. S., El Gendy M. A. M., Seubert J. M., Kleeberger S. R., El-Kadi A. O. S., The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers. Toxicology in Vitro 2011 25 4 785 795 2-s2.0-79955466298 10.1016/j.tiv.2011.01.014
50. Wu K. C., Cui J. Y., Klaassen C. D., Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver. PLoS One 2012 7 7 10.1371/journal.pone.0039006 e39006
51. Cho K. W., Zhou Y., Sheng L., Rui L., Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms. Molecular and Cellular Biology 2011 31 3 450 457 2-s2.0-78751499277 10.1128/MCB.00459-10
52. Wintour E. M., Henry B. A., Glycerol transport: an additional target for obesity therapy? Trends in Endocrinology and Metabolism 2006 17 3 77 78 2-s2.0-33645892554 10.1016/j.tem.2006.01.009
53. García F., Kierbel A., Larocca M. C., Gradilone S. A., Splinter P., LaRusso N. F., Marinelli R. A., The water channel aquaporin-8 is mainly intracellular in rat hepatocytes, and its plasma membrane insertion is stimulated by cyclic AMP. Journal of Biological Chemistry 2001 276 15 12147 12152 2-s2.0-0035853805 10.1074/jbc.M009403200
54. Pilka E. S., Niesen F. H., Lee W. H., El-Hawari Y., Dunford J. E., Kochan G., Wsol V., Martin H. J., Maser E., Oppermann U., Structural basis for substrate specificity in human monomeric carbonyl reductases. PLoS ONE 2009 4 10, article e7113 2-s2.0-70449348378 10.1371/journal.pone.0007113
55. Chang Y. C., Liu P. H., Tsai Y. C., Chiu Y. F., Shih S. R., Ho L. T., Lee W. J., Lu C. H., Quertermous T., Curb J. D., Lee W. J., Lee P. C., He Y. H., Yeh J. I., Hwang J. J., Tsai S. H., Chuang L. M., Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis. Journal of Molecular Medicine 2012 90 7 847 858
56. Cheng Q., Kalabus J. L., Zhang J., Blanco J. G., A conserved antioxidant response element (ARE) in the promoter of human carbonyl reductase 3 (CBR3) mediates induction by the master redox switch Nrf2. Biochemical Pharmacology 2012 83 1 139 148 10.1016/j.bcp.2011.09.027
57. Ebert B., Kisiela M., Malátková P., El-Hawari Y., Maser E., Regulation of human carbonyl reductase 3 (CBR3; SDR21C2) expression by Nrf2 in cultured cancer cells. Biochemistry 2010 49 39 8499 8511 2-s2.0-77957288996 10.1021/bi100814d
58. Hu R., Xu C., Shen G., Jain M. R., Khor T. O., Gopalkrishnan A., Lin W., Reddy B., Chan J. Y., Kong A. N. T., Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Letters 2006 243 2 170 192 2-s2.0-33746889956 10.1016/j.canlet.2005.11.050 (Pubitemid 44485856)
59. Hu R., Xu C., Shen G., Jain M. R., Khor T. O., Gopalkrishnan A., Lin W., Reddy B., Chan J. Y., Kong A. N. T., Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray. Life Sciences 2006 79 20 1944 1955 2-s2.0-33749263503 10.1016/j.lfs.2006.06.019 (Pubitemid 44485118)
60. Mitsuishi Y., Taguchi K., Kawatani Y., Shibata T., Nukiwa T., Aburatani H., Yamamoto M., Motohashi H., Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 2012 22 1 66 79
61. Lazar M. A., Birnbaum M. J., Physiology. De-meaning of metabolism. Science 2012 336 6089 1651 1652 10.1126/science.1221834